THURSDAY, May 30, 2024 (HealthDay News) — Cancer patients receive less effective treatment at hospitals that mainly serve minority communities, a new study shows. More than 9% of cancer patients are treated at hospitals where a significant percentage of patients are from minority groups, researchers say. Those patients are lessContinue Reading

WEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heartContinue Reading

FRIDAY, March 22, 2024 (HealthDay News) — Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, U.S. officials announced Thursday. The move comes after the U.S. Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label earlierContinue Reading

WEDNESDAY, March 13, 2024 (HealthDay News) — Following a cyberattack on the largest health insurer in the United States last month, health care providers continue to scramble as insurance payments and prescription orders continue to be disrupted and physicians lose an estimated $100 million a day. That estimate was generatedContinue Reading

WEDNESDAY, Dec. 13, 2023 (HealthDay News) — An overwhelming majority of older Americans think health insurers and Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy or Zepbound, a new survey has found. More than four out of five older adults (83%) think insurance companies should pay forContinue Reading

THURSDAY, Nov. 16, 2023 (HealthDay News) — If you need medical care, you’re more likely to skip it due to cost issues if you’re American than if you’re Australian, Canadian, British or French, a new report finds. Rising costs aren’t just causing poorer Americans to forgo needed care: The CommonwealthContinue Reading